This article is about contaminated generics, but we think it explains and justifies some of FIP Fighters’ concerns about use of unapproved substances and drugs. Please read it thoroughly and carefully. It explains that generics are not the same as or identical to name brand drugs. Contamination problems were caused by active pharmaceutical ingredients manufactured in China and India. There are still manufacturing problems in those countries, and the FDA has stepped up its presence and manufacturing inspections in both countries.
Drugs alleging to be GC376 and GS441524 are not generic versions of the drugs in the clinical trials, nor have their safety and efficacy been established.
Understanding FIP and how to diagnose the illness took decades. Even today, FIP is sometimes misdiagnosed. Treatment has until today focused on merely making cats comfortable until death inevitably occurs, There are some drugs whi...
Winn Feline Foundation Announces a Special Call
for Research Grant Proposals for Feline Infectious Peritonitis
For Immediate Release
Winn Feline Foundation Call for Research Proposals
Wyckoff, NJ: August 29, 2018
Winn Feline Foundation is a non-profit, charitable organization that funds research into health issues affecting cats.
Specific Subject Areas: Research pertaining to feline infectious peritonitis (FIP), including genetics/molecular biology, prevention, diagnostics, and safe and effective treatment.
Winn Feline Foundation, in a special funding opportunity made possible through The Bria Fund for FIP Research, is calling for proposals that address genetics/molecular biology, prevention, novel diagnostics,...
Increased FIP research is important and needed, but an important reminder! We need to ensure published research is from a credible source. Legitimate FIP research is peer reviewed and accepted by research experts involved in the publication it appears in. Once accepted and published in a credible publication, news of it is widely shared. The process of acceptance and publication can be quite difficult at times. It often requires additional information and resubmission, until accepted. Dr. Pedersen is in the process of submitting Luna's clinical trial for publication. Despite it not being published, including the trial’s protocol, and the exact formula of the drug proprietary, (totally the private property of...